BILIBILI INC-SPONSORED ADR (BILI) Stock Fundamental Analysis

NASDAQ:BILI • US0900401060

30.62 USD
-0.53 (-1.7%)
Last: Feb 19, 2026, 12:58 PM
Fundamental Rating

3

Taking everything into account, BILI scores 3 out of 10 in our fundamental rating. BILI was compared to 69 industry peers in the Interactive Media & Services industry. BILI may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, BILI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • BILI had positive earnings in the past year.
  • In the past 5 years BILI always reported negative net income.
  • In multiple years BILI reported negative operating cash flow during the last 5 years.
BILI Yearly Net Income VS EBIT VS OCF VS FCFBILI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B -6B

1.2 Ratios

  • BILI has a Return On Assets (1.93%) which is comparable to the rest of the industry.
  • With a decent Return On Equity value of 5.17%, BILI is doing good in the industry, outperforming 68.12% of the companies in the same industry.
  • BILI has a Return On Invested Capital of 2.35%. This is comparable to the rest of the industry: BILI outperforms 57.97% of its industry peers.
Industry RankSector Rank
ROA 1.93%
ROE 5.17%
ROIC 2.35%
ROA(3y)-12.19%
ROA(5y)-12.45%
ROE(3y)-30.75%
ROE(5y)-32.63%
ROIC(3y)N/A
ROIC(5y)N/A
BILI Yearly ROA, ROE, ROICBILI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

  • Looking at the Profit Margin, with a value of 2.59%, BILI is in the better half of the industry, outperforming 60.87% of the companies in the same industry.
  • With a Operating Margin value of 2.51%, BILI perfoms like the industry average, outperforming 53.62% of the companies in the same industry.
  • With a Gross Margin value of 36.36%, BILI is not doing good in the industry: 73.91% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of BILI has grown nicely.
Industry RankSector Rank
OM 2.51%
PM (TTM) 2.59%
GM 36.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.17%
GM growth 5Y13.25%
BILI Yearly Profit, Operating, Gross MarginsBILI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BILI is destroying value.
  • The number of shares outstanding for BILI has been increased compared to 1 year ago.
  • BILI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BILI has an improved debt to assets ratio.
BILI Yearly Shares OutstandingBILI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BILI Yearly Total Debt VS Total AssetsBILI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

2.2 Solvency

  • A Debt/Equity ratio of 0.65 indicates that BILI is somewhat dependend on debt financing.
  • BILI has a worse Debt to Equity ratio (0.65) than 69.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.43
WACC5.47%
BILI Yearly LT Debt VS Equity VS FCFBILI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B 20B

2.3 Liquidity

  • BILI has a Current Ratio of 1.64. This is a normal value and indicates that BILI is financially healthy and should not expect problems in meeting its short term obligations.
  • BILI has a Current ratio of 1.64. This is comparable to the rest of the industry: BILI outperforms 43.48% of its industry peers.
  • BILI has a Quick Ratio of 1.64. This is a normal value and indicates that BILI is financially healthy and should not expect problems in meeting its short term obligations.
  • BILI has a Quick ratio (1.64) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.64
BILI Yearly Current Assets VS Current LiabilitesBILI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

6

3. Growth

3.1 Past

  • BILI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 305.65%, which is quite impressive.
  • The Revenue has grown by 16.95% in the past year. This is quite good.
  • BILI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.68% yearly.
EPS 1Y (TTM)305.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%231.58%
Revenue 1Y (TTM)16.95%
Revenue growth 3Y11.45%
Revenue growth 5Y31.68%
Sales Q2Q%5.2%

3.2 Future

  • Based on estimates for the next years, BILI will show a very strong growth in Earnings Per Share. The EPS will grow by 208.10% on average per year.
  • BILI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.77% yearly.
EPS Next Y8483.45%
EPS Next 2Y985.16%
EPS Next 3Y439.84%
EPS Next 5Y208.1%
Revenue Next Year12.84%
Revenue Next 2Y11.13%
Revenue Next 3Y10.39%
Revenue Next 5Y9.77%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BILI Yearly Revenue VS EstimatesBILI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10B 20B 30B 40B 50B
BILI Yearly EPS VS EstimatesBILI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 -10 20 30

3

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 41.38, the valuation of BILI can be described as expensive.
  • The rest of the industry has a similar Price/Earnings ratio as BILI.
  • BILI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.27.
  • With a Price/Forward Earnings ratio of 26.11, BILI can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as BILI.
  • BILI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.16, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 41.38
Fwd PE 26.11
BILI Price Earnings VS Forward Price EarningsBILI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • BILI's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.75
BILI Per share dataBILI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • BILI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • BILI's earnings are expected to grow with 439.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y985.16%
EPS Next 3Y439.84%

0

5. Dividend

5.1 Amount

  • BILI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BILIBILI INC-SPONSORED ADR

NASDAQ:BILI (2/19/2026, 12:58:56 PM)

30.62

-0.53 (-1.7%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)11-13
Earnings (Next)03-05
Inst Owners10.12%
Inst Owner Change3.54%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap12.48B
Revenue(TTM)29.76B
Net Income(TTM)770.09M
Analysts82.78
Price Target30.84 (0.72%)
Short Float %3.96%
Short Ratio6.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.47%
Min EPS beat(2)5.79%
Max EPS beat(2)23.15%
EPS beat(4)4
Avg EPS beat(4)20.04%
Min EPS beat(4)5.79%
Max EPS beat(4)41.24%
EPS beat(8)7
Avg EPS beat(8)14.68%
EPS beat(12)10
Avg EPS beat(12)11.47%
EPS beat(16)13
Avg EPS beat(16)8.56%
Revenue beat(2)0
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-1.82%
Max Revenue beat(2)-1.56%
Revenue beat(4)0
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-1.82%
Max Revenue beat(4)-0.72%
Revenue beat(8)1
Avg Revenue beat(8)-1.11%
Revenue beat(12)1
Avg Revenue beat(12)-1.52%
Revenue beat(16)1
Avg Revenue beat(16)-1.52%
PT rev (1m)1.06%
PT rev (3m)5.06%
EPS NQ rev (1m)-0.37%
EPS NQ rev (3m)-0.8%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)5.16%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)0.69%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 41.38
Fwd PE 26.11
P/S 2.9
P/FCF N/A
P/OCF N/A
P/B 5.79
P/tB 9.34
EV/EBITDA 18.75
EPS(TTM)0.74
EY2.42%
EPS(NY)1.17
Fwd EY3.83%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.57
BVpS5.29
TBVpS3.28
PEG (NY)0
PEG (5Y)N/A
Graham Number9.39
Profitability
Industry RankSector Rank
ROA 1.93%
ROE 5.17%
ROCE 3.18%
ROIC 2.35%
ROICexc 36.78%
ROICexgc N/A
OM 2.51%
PM (TTM) 2.59%
GM 36.36%
FCFM N/A
ROA(3y)-12.19%
ROA(5y)-12.45%
ROE(3y)-30.75%
ROE(5y)-32.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.17%
GM growth 5Y13.25%
F-ScoreN/A
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA 2.98
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.64
Quick Ratio 1.64
Altman-Z N/A
F-ScoreN/A
WACC5.47%
ROIC/WACC0.43
Cap/Depr(3y)66.04%
Cap/Depr(5y)95.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)12.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)305.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%231.58%
EPS Next Y8483.45%
EPS Next 2Y985.16%
EPS Next 3Y439.84%
EPS Next 5Y208.1%
Revenue 1Y (TTM)16.95%
Revenue growth 3Y11.45%
Revenue growth 5Y31.68%
Sales Q2Q%5.2%
Revenue Next Year12.84%
Revenue Next 2Y11.13%
Revenue Next 3Y10.39%
Revenue Next 5Y9.77%
EBIT growth 1Y126.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year388.74%
EBIT Next 3Y86.19%
EBIT Next 5Y49.77%
FCF growth 1Y500.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2155.95%
OCF growth 3YN/A
OCF growth 5Y98.62%

BILIBILI INC-SPONSORED ADR / BILI FAQ

Can you provide the ChartMill fundamental rating for BILIBILI INC-SPONSORED ADR?

ChartMill assigns a fundamental rating of 3 / 10 to BILI.


Can you provide the valuation status for BILIBILI INC-SPONSORED ADR?

ChartMill assigns a valuation rating of 3 / 10 to BILIBILI INC-SPONSORED ADR (BILI). This can be considered as Overvalued.


How profitable is BILIBILI INC-SPONSORED ADR (BILI) stock?

BILIBILI INC-SPONSORED ADR (BILI) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for BILI stock?

The Price/Earnings (PE) ratio for BILIBILI INC-SPONSORED ADR (BILI) is 41.38 and the Price/Book (PB) ratio is 5.79.


How financially healthy is BILIBILI INC-SPONSORED ADR?

The financial health rating of BILIBILI INC-SPONSORED ADR (BILI) is 2 / 10.